Evaluation of the Residual Antimicrobial Efficacy of One Test Material Based on a Modification of ASTM E1115-11 Test Method

Phase 4 Completed 32 enrolled Molnlycke Health Care AB BioScience Laboratories, Inc. · collab

NaSingle-groupOpen-labelOther

Summary

To evaluate the residual antimicrobial effectiveness of one test product when tested using a modification of the methodology of the standardized ASTM E115-11 (2017)

Timeline

Start: 2020-11-30
Primary completion: 2020-12-24
Completion: 2020-12-24

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Chlorhexidine gluconate	Other / unclassified	—	—

Indications

No indication recorded.